Cilmostim

Drug Profile

Cilmostim

Alternative Names: CSF-1; M-CSF; Macrophage colony-stimulating factor - Genetics Institute; Macstim; Recombinant human macrophage colony stimulating factor; rhM-CSF

Latest Information Update: 14 Aug 1996

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Wyeth
  • Developer Schering-Plough; Wyeth
  • Class Macrophage colony stimulating factors
  • Mechanism of Action Macrophage colony stimulating factor stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Cancer; Hypercholesterolaemia

Most Recent Events

  • 14 Aug 1996 Discontinued-II for Hypercholesterolaemia in USA (Unknown route)
  • 07 Aug 1996 Discontinued-II for Cancer in USA (IV)
  • 07 Aug 1996 Phase-II clinical trials for Hypercholesterolaemia in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top